Denise Mason

Mar 11, 2023 | nejm.org | Steven Nissen |A. Michael Lincoff |Danielle Brennan |Denise Mason

AbstractBackgroundBempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of muscle-related adverse events; its effects on cardiovascular outcomes remain uncertain. Methods Download a PDF of the Research Summary.